Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2006-09-22

FDA Approved: TOLMETIN SODIUM — Supplemental Application (Atland Pharmaceuticals, LLC)

View source ↗

Summary

FDA approved a supplemental application for tolmetin sodium from Atland Pharmaceuticals, under ANDA074473. This action updates the regulatory approval for this …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tolmetin sodium (Tolmetin sodium)

Snippet

SUPPL AP for TOLMETIN SODIUM (TOLMETIN SODIUM)